Study Links Inflammation Marker Rise to Early Cardiometabolic Risk
Heart disease, kidney problems, and type 2 diabetes can develop over time, but understanding when early warning signs begin to manifest is crucial for prevention. While routine bloodwork provides valuable information, researchers are now focusing on inflammation as a key indicator of health risks. A recent study explored how a common blood marker of inflammation, high-sensitivity C-reactive protein (hsCRP), changes as cardiovascular-kidney-metabolic (CKM) risk develops. The aim was to determine whether these changes occur early, before more serious health issues arise.
The study analyzed health data from 4,315 U.S. adults who participated in the National Health and Nutrition Examination Survey between 2015 and 2018. Researchers measured hsCRP levels to assess inflammation and grouped participants into five CKM stages defined by the American Heart Association. By comparing hsCRP levels across these stages, while accounting for factors such as age, smoking, physical activity, blood pressure, cholesterol, and blood sugar, the researchers aimed to uncover patterns in inflammation related to CKM risk.
The most significant increase in inflammation was observed between Stage 0 and Stage 1, where average hsCRP levels rose by an alarming 89%. This jump occurred when participants transitioned from having no CKM risk factors to having excess or dysfunctional body fat without other CKM risk factors. Additionally, individuals in Stage 1 exhibited 76% higher odds of elevated hsCRP levels compared to those in Stage 0, with elevated levels defined as 2 milligrams per liter or higher, a commonly recognized clinical threshold.
As CKM risk advanced, inflammation levels continued to rise, but the increase was much more gradual. By Stages 2 through 4, hsCRP levels plateaued, indicating that the most substantial change in this marker occurs early in the progression of risk. This sharp rise at Stage 1 may be attributed to the improper functioning of fat tissue, which can release substances that promote inflammation throughout the body.
Factors Influencing Inflammation Levels in Later Stages of Risk
However, as metabolic and kidney issues develop, other factors, including medications and coexisting health conditions, may also influence inflammation levels. This could explain why the relationship between hsCRP and CKM stage became less consistent in later stages of risk.
Understanding the Limitations of Inflammation Research in Cardiometabolic Health
It's important to note a significant limitation of the study. While hsCRP reflects inflammation, it does not establish that inflammation directly causes cardiometabolic diseases. The researchers measured participants' health at a single point in time, which means they could not determine whether inflammation contributed to declining health or merely occurred alongside it. Long-term studies are necessary to fully understand how these changes unfold over time.
You don't need specialized tests to start caring for your heart, kidneys, and metabolism. Simple everyday habits can make a difference. This study underscores the importance of monitoring inflammation levels, as they can change before health problems become apparent. Taking proactive steps to maintain health before a diagnosis is crucial for preventing serious conditions.




